Results 101 to 110 of about 701,572 (291)

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Perioperative management of patients with cardiac implantable electronic devices [PDF]

Korean Journal of Anesthesiology
The use of cardiac implantable electronic devices (CIEDs) has increased significantly in recent years. Consequently, more patients with CIEDs will undergo surgery during their lifetime, and thus the involvement of anesthesiologists in the perioperative ...
Minsu Kim, Chang Hee Kwon
doaj   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Do mobile phones cause dysfunctions of cardiac pacemakers? [PDF]

, 2006
Artykuł prezentuje problematykę badań stymulatorów serca eksponowanych na sztucznie generowane pole elektromagnetyczne przez systemy telefonii komórkowej.
Krawczyk, A., Pławiak-Mowna, A., Koźluk, E.   +2 more
core  

Safety of Repetitive Transcranial Magnetic Stimulation in Patients With Cardiac Pacemakers: A Case Report. [PDF]

J ECT, 2023
Jammigumpula A, Joseph JT, Manibettu V, Purohith AN, Shenoy S, Udupa S, Praharaj SK.   +6 more
europepmc   +1 more source

Comparative Analysis of Extraction Complications in Transvenous Versus Leadless Pacemakers. [PDF]

Cureus
Pacemakers are cardiac implantable electronic devices (CIEDs) that deliver electrical impulses to regulate heart rhythm and manage conditions such as cardiac arrhythmias.
Sahyouni A, Jimenez A, Alrahal J, Knight A, Chen R, Maddineni T, Lugo LA, Koneru A, Ramey K, Subbiondo RJ.   +9 more
europepmc   +2 more sources

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Leadless and symbiotic cardiac pacemakers; as an alternative to conventional pacemakers [PDF]

, 2021
There have been considerable advancements in technology since the first permanent pacemaker was implanted in 1960. A subcutaneous generator and battery module are connected to one or more endocardial leads in the conventional pacemaker implantation ...
Gunes, Yilmaz, Donmez , Ibrahin, Cosgun, Mehmet   +2 more
core  

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Synthetic Megavoltage Cone Beam Computed Tomography Image Generation for Improved Contouring Accuracy of Cardiac Pacemakers. [PDF]

J Imaging, 2023
Baroudi H, Chen X, Cao W, El Basha MD, Gay S, Gronberg MP, Hernandez S, Huang K, Kaffey Z, Melancon AD, Mumme RP, Sjogreen C, Tsai JY, Yu C, Court LE, Pino R, Zhao Y.   +16 more
europepmc   +1 more source